Quarterly results round-up: Hologic profit quadruples on drug payment, while TomoTherapy loss increases
This article was originally published in Clinica
Executive Summary
Women's health specialist Hologic quadrupled its net profit to $82.4m in its second fiscal quarter, boosted by a significant milestone payment for a drug to prevent premature birth.